Operating Lease, Right-of-Use Asset of bluebird bio, Inc. from 01 Jan 2019 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
bluebird bio, Inc. quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 01 Jan 2019 to 31 Mar 2025.
  • bluebird bio, Inc. Operating Lease, Right-of-Use Asset for the quarter ending 31 Mar 2025 was $27,073,000, a 86% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

bluebird bio, Inc. Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $27,073,000 -$168,136,000 -86% 31 Mar 2025 10-Q 14 May 2025 2025 Q1
Q4 2024 $176,883,000 -$24,230,000 -12% 31 Dec 2024 10-Q 14 May 2025 2025 Q1
Q3 2024 $183,098,000 -$111,619,000 -38% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 $189,206,000 -$113,643,000 -38% 30 Jun 2024 10-Q 27 Sep 2024 2024 Q2
Q1 2024 $195,209,000 -$74,944,000 -28% 31 Mar 2024 10-Q 13 Sep 2024 2024 Q1
Q4 2023 $201,113,000 -$29,772,000 -13% 31 Dec 2023 10-K 27 Mar 2025 2024 FY
Q3 2023 $294,717,000 +$6,033,000 +2.1% 30 Sep 2023 10-Q 07 Nov 2023 2023 Q3
Q2 2023 $302,849,000 +$10,118,000 +3.5% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 $270,153,000 +$158,256,000 +141% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 $230,885,000 +$139,353,000 +152% 31 Dec 2022 10-K 13 Sep 2024 2023 FY
Q3 2022 $288,684,000 +$114,249,000 +65% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 $292,731,000 +$101,738,000 +53% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 $111,897,000 -$86,073,000 -43% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 $91,532,000 +$23,969,000 +35% 31 Dec 2021 10-K 29 Mar 2023 2022 FY
Q3 2021 $174,435,000 -$14,015,000 -7.4% 30 Sep 2021 10-Q 05 Nov 2021 2021 Q3
Q2 2021 $190,993,000 +$1,529,000 +0.81% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $197,970,000 +$3,501,000 +1.8% 31 Mar 2021 10-Q 05 May 2021 2021 Q1
Q4 2020 $67,563,000 -$118,322,000 -64% 31 Dec 2020 10-K 04 Mar 2022 2021 FY
Q3 2020 $188,450,000 -$3,113,000 -1.6% 30 Sep 2020 10-Q 04 Nov 2020 2020 Q3
Q2 2020 $189,464,000 -$1,515,000 -0.79% 30 Jun 2020 10-Q 05 Aug 2020 2020 Q2
Q1 2020 $194,469,000 +$9,851,000 +5.3% 31 Mar 2020 10-Q 11 May 2020 2020 Q1
Q4 2019 $185,885,000 +$58,585,000 +46% 31 Dec 2019 10-K 23 Feb 2021 2020 FY
Q3 2019 $191,563,000 30 Sep 2019 10-Q 31 Oct 2019 2019 Q3
Q2 2019 $190,979,000 30 Jun 2019 10-Q 01 Aug 2019 2019 Q2
Q1 2019 $184,618,000 31 Mar 2019 10-Q 03 May 2019 2019 Q1
Q4 2018 $127,300,000 01 Jan 2019 10-Q 31 Oct 2019 2019 Q3
* An asterisk sign (*) next to the value indicates that the value is likely invalid.